334 related articles for article (PubMed ID: 29030241)
1. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
Lu S; Ji M; Ni D; Zhang J
Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
[TBL] [Abstract][Full Text] [Related]
2. Hidden allosteric sites and De-Novo drug design.
Rehman AU; Lu S; Khan AA; Khurshid B; Rasheed S; Wadood A; Zhang J
Expert Opin Drug Discov; 2022 Mar; 17(3):283-295. PubMed ID: 34933653
[TBL] [Abstract][Full Text] [Related]
3. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.
Lu S; He X; Ni D; Zhang J
J Med Chem; 2019 Jul; 62(14):6405-6421. PubMed ID: 30817889
[TBL] [Abstract][Full Text] [Related]
4. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
Huang W; Nussinov R; Zhang J
Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
[TBL] [Abstract][Full Text] [Related]
5. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
[TBL] [Abstract][Full Text] [Related]
6. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.
Sheik Amamuddy O; Veldman W; Manyumwa C; Khairallah A; Agajanian S; Oluyemi O; Verkhivker G; Tastan Bishop O
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013012
[TBL] [Abstract][Full Text] [Related]
7. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
Fronik P; Gaiser BI; Sejer Pedersen D
J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
[TBL] [Abstract][Full Text] [Related]
8. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
Chiappori F; Milanesi L; Merelli I
Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
[TBL] [Abstract][Full Text] [Related]
9. Use of allosteric targets in the discovery of safer drugs.
Grover AK
Med Princ Pract; 2013; 22(5):418-26. PubMed ID: 23711993
[TBL] [Abstract][Full Text] [Related]
10. Current and Future Challenges in GPCR Drug Discovery.
Topiol S
Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
[TBL] [Abstract][Full Text] [Related]
11. Exploiting protein flexibility to predict the location of allosteric sites.
Panjkovich A; Daura X
BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
Platania CBM; Bucolo C
Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
[TBL] [Abstract][Full Text] [Related]
13. Recent computational advances in the identification of allosteric sites in proteins.
Lu S; Huang W; Zhang J
Drug Discov Today; 2014 Oct; 19(10):1595-600. PubMed ID: 25107670
[TBL] [Abstract][Full Text] [Related]
14. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
15. Drugs for allosteric sites on receptors.
Wenthur CJ; Gentry PR; Mathews TP; Lindsley CW
Annu Rev Pharmacol Toxicol; 2014; 54():165-84. PubMed ID: 24111540
[TBL] [Abstract][Full Text] [Related]
16. Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets.
He H; Liu B; Luo H; Zhang T; Jiang J
Stroke Vasc Neurol; 2020 Dec; 5(4):381-387. PubMed ID: 33376199
[TBL] [Abstract][Full Text] [Related]
17. Allosteric drugs and mutations: chances, challenges, and necessity.
Guarnera E; Berezovsky IN
Curr Opin Struct Biol; 2020 Jun; 62():149-157. PubMed ID: 32062398
[TBL] [Abstract][Full Text] [Related]
18. Harnessing allostery: a novel approach to drug discovery.
Lu S; Li S; Zhang J
Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
Lu S; Shen Q; Zhang J
Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
[TBL] [Abstract][Full Text] [Related]
20. Computational Strategy Revealing the Structural Determinant of Ligand Selectivity towards Highly Similar Protein Targets.
Wang H; Gao Y; Wang J; Cheng M
Curr Drug Targets; 2020; 21(1):76-88. PubMed ID: 31556854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
